2026-05-06 00:07:47
Latest Post
Lloyds Metals and Energy Ltd reports consolidated PAT of Rs. 1419.50 crores in Q4FY26
United Breweries Ltd consolidated Q4FY26 net profit up at Rs. 101.78 crores
Kriti Nutrients Ltd Q4 FY2026 consolidated PAT at Rs. 6.19 crores
B-Right Realestate Ltd consolidated Q4FY26 PAT jumps to Rs. 33.42 crores
Aeroflex Industries Ltd reports Rs. 17.63 crores consolidated PAT in Q4 FY2025-26
Stock Report
Sandu Pharmaceuticals Ltd Q4 FY2025-26 net profit at Rs. 4.34 lakhs
Posted On : 2026-05-05 22:12:07( TIMEZONE : IST )
SANDU PHARMACEUTICALS LTD. has reported Standalone financial results for the period ended March 31, 2026.
Financial Results (Q4 FY2026) - QoQ Comparison
The company has reported total income of Rs. 17.2185 crores during the period ended March 31, 2026 as compared to Rs. 18.7746 crores during the period ended December 31, 2025.
The company has posted net profit / (loss) of Rs. 0.0434 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 0.9751 crores for the period ended December 31, 2025.
The company has reported EPS of Rs. 0.04 for the period ended March 31, 2026 as compared to Rs. 1.01 for the period ended December 31, 2025.
| Financials | Q4 FY2026 | Q3 FY2026 | % Change |
| Total Income | ₹ 17.2185 crs | ₹18.7746 crs |  -8.29% |
| Net Profit | ₹0.0434 crs | ₹0.9751 crs | -95.55% |
| EPS | ₹0.04 | ₹1.01 | -96.04% |
Financial Results (Q4 FY2026) - YoY Comparison
The company has reported total income of Rs. 17.2185 crores during the period ended March 31, 2026 as compared to Rs.14.1385 crores during the period ended March 31, 2025.
The company has posted net profit / (loss) of Rs.0.0434 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.0.3264 crores for the period ended March 31, 2025.
The company has reported EPS of Rs.0.04 for the period ended March 31, 2026 as compared to Rs.0.34 for the period ended March 31, 2025.
| Financials | Q4 FY2026 | Q4 FY2025 | % Change |
| Total Income | ₹ 17.2185 crs | ₹14.1385 crs |  21.78% |
| Net Profit | ₹0.0434 crs | ₹0.3264 crs | -86.70% |
| EPS | ₹0.04 | ₹0.34 | -88.24% |
Financial Results (Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.70.3789 crores during the Financial Year ended March 31, 2026 as compared to Rs.67.3599 crores during the Financial Year ended March 31, 2025.
The company has posted net profit / (loss) of Rs.1.7661 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.1.5489 crores for the Financial Year ended March 31, 2025.
The company has reported EPS of Rs.1.83 for the Financial Year ended March 31, 2026 as compared to Rs.1.60 for the Financial Year ended March 31, 2025.
| Financials | Year Ended FY2026 | Year Ended FY2025 | % Change |
| Total Income | ₹70.3789 crs | ₹67.3599 crs | 4.48% |
| Net Profit | ₹1.7661 crs | ₹1.5489 crs | 14.02% |
| EPS | ₹1.83 | ₹1.60 | 14.38% |
Shares of SANDU PHARMACEUTICALS LTD. was last trading in BSE at Rs. 42.11 as compared to the previous close of Rs. 42.99. The total number of shares traded during the day was 9614 in over 68 trades.
The stock hit an intraday high of Rs. 44.65 and intraday low of 42.00. The net turnover during the day was Rs. 412484.00.
